Cutaneous Large B Cell Lymphoma Involving the Duodenum and the Bile Duct: a Case Report

  • Lamine Hamzaoui
  • Mouna Medhioub
  • Amal Khsiba
  • Moufida Mahmoudi
  • Talel Badri
  • Mohamed Msaddak Azouz
Case Report
  • 7 Downloads

Abbreviations

PCBCL

primary cutaneous B cell lymphoma

EBV

Epstein-Barr virus

EBER

Epstein-Barr encoded RNA

ALP

alkaline phosphatase

GGT

gamma-glutamyl-transpeptidase

AST

aspartate amino transferase

ALT

alanine transferase

PT

prothrombin time

CA 19-9

Cancer antigen 19-9

HIV

human immunodeficiency virus

MRCP

magnetic resonance cholangiopancreatography

CT scan

computed tomography scan

CBD

common bile duct

ERCP

endoscopic retrograde cholangiopancreatography

R-CHOP

rituximab, cyclophosphamide, vincristine, doxorubicin, and prednisolone

Notes

Compliance with Ethical Standards

Informed Consent

Informed consent was not obtained because the patient died and we have no contact of his relatives (unreachable by phone and other methods).

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Huang CT, Yang WC, Liu YC, Lin SF. Primary cutaneous diff use large B-cell lymphoma, leg type, with unusual clinical presentation of bluish reddish multicolored rainbow pattern. J Clin Oncol. 2011;29(17):e497–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Senff NJ, Noordijk EM, Kim YH, Bagot M, Berti E, Cerroni L, et al. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood. 2008;112(5):1600–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Feller E, Schiffman FJ. Extrahepatic biliary obstruction by lymphoma. Arch Surg. 1990;125(11):1507–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Thomas V, Dobson R, Mennel R. Primary cutaneous large B-cell lymphoma, leg type. Proc (Bayl Univ Med Cent). 2011;24(4):350–3.CrossRefGoogle Scholar
  5. 5.
    Yalçin S, Kars A, Sökmensüer C, Atahan L. Extrahepatic Hodgkin’s disease with intrahepatic cholestasis: report of two cases. Oncology. 1999;57(1):83–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Di Sena V, Thuler FP, Macedo EP, Paulo GA, Della Libera E, Ferrari AP. Obstructive jaundice secondary to bile duct involvement with Hodgkin’s disease: a case report. Sao Paulo Med J. 2005;123(1):30–2.CrossRefPubMedGoogle Scholar
  7. 7.
    Joo YE, Park CH, Lee WS, Kim HS, Choi SK, Cho CK, et al. Primary non-Hodgkin’s lymphoma of the common bile duct presenting as obstructive jaundice. J Gastroenterol. 2004;39:692–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Senff NJ, Hoefnagel JJ, Neelis KJ, Vermeer MH, Noordijk EM, Willemze R. Dutch cutaneous lymphoma group. Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHOEORTC classification. Arch Dermatol. 2007;143(12):1520–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Lamine Hamzaoui
    • 1
    • 2
  • Mouna Medhioub
    • 1
    • 2
  • Amal Khsiba
    • 1
    • 2
  • Moufida Mahmoudi
    • 1
    • 2
  • Talel Badri
    • 2
    • 3
  • Mohamed Msaddak Azouz
    • 1
    • 2
  1. 1.Gastroenterology DepartmentMohamed Tahar Maamouri HospitalNabeulTunisia
  2. 2.Faculty of Medicine of TunisTunis El Manar UniversityTunisTunisia
  3. 3.Dermatology DepartmentHabib Thameur HospitalTunisTunisia

Personalised recommendations